Team Science Award supports interdisciplinary investigator teams developing collaborative cancer research that advances Hollings Cancer Center priorities and builds potential for future external funding.
Funds collaborative research teams for translational and early clinical studies that advance early detection, diagnosis, and risk stratification of melanoma, with required patient partner involvement.
Partnership Awards support researchers collaborating across academia, industry, and nonprofit organizations on translational research to advance melanoma prevention, diagnosis, staging, and treatment.
Pilot Awards support melanoma researchers testing high-risk, innovative hypotheses to establish translational proof-of-concept and advance melanoma prevention, diagnosis, staging, and treatment.
2026-2027 Request for Proposals supports established and young investigators advancing melanoma research to deliver near-term improvements in prevention, detection, diagnosis, and treatment.